PLX
Protalix BiotherapeuticsANYSE American / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
PLX vs peer average
80/100
PLX vs. peer average (A vs. C)
Grade spread
A 2 · B 1 · C 4 · D 2 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
TAK is the first available peer comparator.
Takeda's Replagal is a Fabry-treatment product comparator, not a close small-cap equity-valuation peer.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
PLX
Protalix Biotherapeutics
TAK
Takeda Pharmaceutical
Grade
A
C
Momentum
98
90
Value
64
63
Sentiment
70
39
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Mixed
Grade position vs TAK
PLX / TAK
Grade Position
Above peers
PLX vs. peer average (A vs. C)
80/100
Momentum
98
PLXValue
64
PLXSentiment
70
PLXRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs PLX
TAK is the first peer returned for this comparison set.